31 January 2001 Novel photosensitizers for prospective clinical usage and some of their properties
Author Affiliations +
Proceedings Volume 4156, Clinical Lasers and Diagnostics; (2001); doi: 10.1117/12.413699
Event: EOS/SPIE European Biomedical Optics Week, 2000, Amsterdam, Netherlands
Abstract
Five novel photosensitizers for photodynamic tumor therapy have been offered as potential drug substances for the prospective clinical usage. A complex of pre-clinic biological studies has been performed, unambiguously demonstrating low systemic toxicity and high photodynamic potential of the substances proposed. The one named 'Photodithazine/Photochlorin I' has already successfully passed a number of clinical test on patients having immergent vital indications.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Andrei V. Reshetnickov, Stefan B. Spaniol, N. P. Neugodova, G. A. Sapozhnikova, Olga Yu. Abakumova, Tatyana A. Tsvetkova, Igor Dmitrievich Zalevsky, S. E. Goncharov, Artashes V. Karmenyan, Gelii V. Ponomarev, "Novel photosensitizers for prospective clinical usage and some of their properties", Proc. SPIE 4156, Clinical Lasers and Diagnostics, (31 January 2001); doi: 10.1117/12.413699; https://doi.org/10.1117/12.413699
PROCEEDINGS
5 PAGES


SHARE
KEYWORDS
Magnesium

Photodynamic therapy

Toxicity

Cancer

Tumors

Picosecond phenomena

Oncology

Back to Top